• Chỉ mục bởi
  • Năm xuất bản
LIÊN KẾT WEBSITE

A novel synonymous mutation of SARS-COV-2: Is this possible to affect their antigenicity and immunogenicity?

Kim S.-J. Department of Veterinary Medicine Virology Lab, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul, 08826, South Korea|
Chung H.-C. | Park B.-K. | Park Y.-H. Department of Veterinary Microbiology, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul, 151-742, South Korea| Nguyen V.-G. Department of Veterinary Microbiology and Infectious Diseases, Faculty of Veterinary Medicine, Vietnam National University of Agriculture, Hanoi, 100000, Viet Nam|

Vaccines Số 2, năm 2020 (Tập 8, trang -)

ISSN: 2076393X

ISSN: 2076393X

DOI: 10.3390/vaccines8020220

Tài liệu thuộc danh mục: Scopus

Article

English

Từ khóa: epitope; amino acid substitution; antigenicity; Article; coronavirus disease 2019; gene; gene mutation; gene sequence; human; immune system; immunogenicity; phylogeny; S gene; SARS coronavirus; serology; Severe acute respiratory syndrome coronavirus 2; synonymous mutation
Tóm tắt tiếng anh
The S glycoprotein of coronaviruses is important for viral entry and pathogenesis with most variable sequences. Therefore, we analyzed the S gene sequences of SARS-CoV-2 to better understand the antigenicity and immunogenicity of this virus in this study. In phylogenetic analysis, two subtypes (SARS-CoV-2a and-b) were confirmed within SARS-CoV-2 strains. These two subtypes were divided by a novel synonymous mutation of D614G. This may play a crucial role in the evolution of SARS-CoV-2 to evade the host immune system. The region containing this mutation point was confirmed as a B-cell epitope located in the S1 domain, and SARS-CoV-2b strains exhibited severe reduced antigenic indexes compared to SARS-CoV-2a in this area. This may allow these two subtypes to have different antigenicity. If the two subtypes have different serological characteristics, a vaccine for both subtypes will be more effective to prevent COVID-19. Thus, further study is urgently required to confirm the antigenicity of these two subtypes. � 2020 by the authors. Licensee MDPI, Basel, Switzerland.

Xem chi tiết